X

Brian Robins

Stock valuations are surging as medtech embraces SAAS

The ‘software as a service’ (SAAS) business model has taken off in the computer software sector over the past few…

Can Aussie Venture Capital-backed IPO’s brush off the negativity around US unicorns going public?

Late last month, co-working space outfit WeWork pulled its planned US IPO when investors turned squeamish over its valuations. At…

A poor track record dogs US plays on the ASX

When it comes to buying shares in US entities which list on the ASX, investors could be forgiven if they…

Alkane wants to spin out its rare earths project as global demand heats up

Competition to get the next rare earths project off the ground is hotting up, with Alkane Resources (ASX:ALK) confirming that…

EdTech on the ASX: It’s an emerging thing

Online learning may have been around for quite some time, but education technology (EdTech) as an investment option on the…

The life sciences investment wave is building. Here’s how to ride it.

Strong gains among selected life science shares is fuelling optimism that the sector may have further to run. Life sciences…

Asian investors are targeting Aussie stocks. Here’s what they’re aiming for

E-sports, technology, biotech and primary producer stocks are all experiencing growing interest from Asian investors. This partially reflects rising investor…

Car insured with AAMI, GIO, Bingle? Guess who’ll fix your next prang

Insure your car via AAMI, GIO, or Bingle? If you have a ‘bingle’, chances are you could end up having…

Gold is good, but which miners are offering the best returns?

A rising tide lifts all ships, as the old saying goes. But does it apply to gold miners and explorers?…

Clinuvel surges to all-time high on US green light

Ending years of uncertainty, shares in skin treatment specialist Clinuvel (ASX:CUV) surged to all-time highs this morning after it received…

‘Dr Copper’ woes loom over mining minnows

It’s not called “Doctor copper” for nothing as wariness over the outlook for global economic growth has prompted some analysts…

Brain apps hit their stride as deals start to flow

Getting traction has taken time. But for the likes of Cogstate (ASX:CGS) and Total Brain (ASX:TTB), which have developed online…

Is commission-free share trading coming to Australia?

It’s taken longer than expected, but zero commissions on share trades went mainstream in the US last week. And this…

Clinuvel shares seesaw as D-Day approaches

It’s an unusual day in recent trading when shares in biotech stock Clinuvel Pharmaceutical (ASX:CUV) haven’t risen or fallen by…

How to ride Alibaba’s plans to expand China’s e-commerce market

Selling into the giant China market isn’t easy, as investors in the three ASX-listed China consumer spending plays have found,…

The minefield of investing in software stocks

Is investing in local software companies worth the bother? Investing in software companies is not for the unwary, with ARQ…

Why a drone attack on Saudi oil supplies is good news for ASX producers… and some explorers

The lift in the price of oil to six month highs on the threat of Middle East supply disruptions has…